Teleflex Incorporated (NYSE:TFX) Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB trimmed its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,500 shares of the medical technology company’s stock after selling 422 shares during the period. Handelsbanken Fonder AB’s holdings in Teleflex were worth $2,119,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Venturi Wealth Management LLC lifted its position in shares of Teleflex by 33.3% during the 4th quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock valued at $46,000 after acquiring an additional 46 shares during the period. Huntington National Bank lifted its position in shares of Teleflex by 26.5% during the 3rd quarter. Huntington National Bank now owns 253 shares of the medical technology company’s stock valued at $50,000 after acquiring an additional 53 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of Teleflex by 1.5% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 3,767 shares of the medical technology company’s stock valued at $740,000 after acquiring an additional 56 shares during the period. Lindbrook Capital LLC lifted its position in shares of Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 58 shares during the period. Finally, Asset Management One Co. Ltd. lifted its position in shares of Teleflex by 0.3% during the 3rd quarter. Asset Management One Co. Ltd. now owns 19,230 shares of the medical technology company’s stock valued at $3,777,000 after acquiring an additional 60 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

TFX stock opened at $206.71 on Friday. The stock has a market capitalization of $9.74 billion, a P/E ratio of 27.45, a PEG ratio of 1.98 and a beta of 1.11. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.29 and a current ratio of 2.32. Teleflex Incorporated has a one year low of $177.63 and a one year high of $276.43. The company has a 50 day moving average price of $221.23 and a two-hundred day moving average price of $225.61.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating analysts’ consensus estimates of $3.26 by $0.12. The company had revenue of $773.90 million for the quarter, compared to analyst estimates of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. Teleflex’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the business earned $3.52 EPS. As a group, sell-side analysts expect that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a $0.34 dividend. The ex-dividend date was Thursday, February 29th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.66%. Teleflex’s dividend payout ratio (DPR) is presently 18.06%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on TFX. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Truist Financial dropped their price objective on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research note on Friday, February 23rd. JMP Securities reissued a “market outperform” rating and set a $285.00 price objective on shares of Teleflex in a research note on Friday, February 23rd. Finally, Royal Bank of Canada dropped their price objective on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $267.50.

Insider Buying and Selling at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of Teleflex stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares in the company, valued at approximately $2,261,250. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.43% of the stock is owned by company insiders.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.